-
Innovation Ranking
NewInnovation Ranking – ITM Semiconductor Co Ltd
ITM Semiconductor Co Ltd (ITM Semiconductor) is a technology company that carries out the research and development, manufactures and sells semiconductor devices. The company offering products includes protection one chip (POC), protection module package (PMP), battery pack, sensor module package, NFC chip antenna and wireless charger. Its battery pack offers polymer battery pack and square battery pack. It also provides BMS battery management system which includes master BMS and slave BMS. ITM Semiconductor services comprises product planning, software development, circuit...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ITM-22 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ITM-22 in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ITM-22 in Prostate Cancer Drug Details: ITM-22 is under development for the...
-
Company Insights
Innovation and Patenting activity of ITM Power Plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ITM Power Plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of ITM Semiconductor Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ITM Semiconductor Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ITM-52 in Adenocarcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ITM-52 in Adenocarcinoma Drug Details: ITM-52 is under development for the treatment of solid tumors...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ITM-52 in Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ITM-52 in Ovarian Cancer Drug Details: ITM-52 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ITM-52 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ITM-52 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ITM-52 in Solid Tumor Drug Details:ITM-52 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Transitional Cell Carcinoma (Urothelial Cell...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Onureg in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onureg in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onureg in Marginal Zone B-cell Lymphoma Drug Details: Azacitidine (Onureg)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ITM-31 in Glioblastoma Multiforme (GBM)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ITM-31 in Glioblastoma Multiforme (GBM) Drug Details: ITM-31 is under development for the treatment...